|The RPL38 n/a (Catalog #MBS646558) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The RPL38 (60S Ribosomal Protein L38) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s RPL38 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot. Researchers should empirically determine the suitability of the RPL38 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The RPL38 n/a product has the following accession number(s) (GI #527312337) (NCBI Accession #EPT28967.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
60S ribosomal protein L38 is a protein that in humans is encoded by the RPL38 gene.This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L38E family of ribosomal proteins.
Immunogen: Recombinant corresponding to human RPL38. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing RPL38 are readily searchable from our website. Different antibodies against the same target such as RPL38 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.